SMITH PHILIP IRVING 4

What Happened
Philip Irving Smith, a director of Park Dental Partners, was granted 2,632 restricted stock units (RSUs) on June 15, 2026. The award was recorded as an acquisition of a derivative security (code A) at $0.00 cash consideration. Each RSU represents a contingent right to one share of PARK common stock upon vesting.

Key Details

• Transaction date: 2026-06-15 (Form 4 filed 2026-06-22). The filing appears to have been submitted 7 days after the transaction, which is later than the typical 2-business-day Form 4 deadline.
• Security: 2,632 Restricted Stock Units (derivative of common stock). Reported price: $0.00 (granted for no cash consideration). (Footnotes: F1–F3)
• Vesting: RSUs vest in full on the first anniversary of the grant date, subject to continued service as a director and the award agreement (per footnote).
• Shares owned after transaction: not specified in the information provided.
• Transaction code: A (award/grant). No tax withholding, sale, or exercise reported in this filing.

Context
This is a grant of deferred equity (RSUs), not an open-market purchase or sale. RSU grants compensate or retain directors and do not themselves indicate immediate buying or selling of shares; the economic exposure depends on whether and when the units vest and shares are delivered. The late filing may be a compliance issue for the insider/company and could attract SEC inquiry or require an explanation in subsequent disclosures.